Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Identifying novel drug targets that transition from pre-clinical testing to human trials is a scientific priority. To that end, here we describe a functional genomics approach for examining the impact of gene depletion on cancer cell line spheroids, which more appropriately model human cancers in...

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Heterogeneous distribution of HER2-positive cells can be observed in a subset of breast cancers and generates clinical dilemmas. Here, we introduce a reliable and cost-effective protocol to define, quantify, and compare HER2 intra-tumor genetic heterogeneity in a large series of heterogeneously processed breast...

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

This work presets an advanced protocol to accurately assess tumor loading by detection of green fluorescent protein and bioluminescence signals as well as the integration of quantitative molecular detection...

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Patient-derived xenograft (PDX) models and transplantable genetically engineered mouse models faithfully recapitulate human disease and are preferred models for basic and translational breast cancer research. Here, a method is described to orthotopically transplant breast tumor fragments into the mammary fat pad to study tumor biology and evaluate drug...

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

This protocol describes the construction of an in vitro microphysiological system for studying breast cancer using primary human breast tissue with off the shelf...

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish

Here, we describe xenograft zebrafish models using two different injection sites, i.e., perivitelline space and duct of Cuvier, to investigate the invasive behavior and to assess the intravasation and extravasation potential of human breast cancer cells,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Centers for Medicare and Medicaid Services staffing regulations in critical access hospitals: Implications for nurse practitioner practice and rural care access.

Journal of the American Association of Nurse Practitioners·2026

Same journal

Atrial fibrillation detection with implantable loop recorders in a community-based cardiology practice: Limited discriminatory value of echocardiographic structural markers.

Journal of the American Association of Nurse Practitioners·2026

Same journal

From the AANP Board of Directors-Leadership development.

Journal of the American Association of Nurse Practitioners·2026

Same journal

The effect of pain neuroscience education program on patients with chronic low back pain.

Journal of the American Association of Nurse Practitioners·2026

Same journal

A Spanish-language educational intervention to enhance diabetes outcomes among existing continuous glucose monitor users in a federally qualified health care center.

Journal of the American Association of Nurse Practitioners·2026

Same journal

Evaluating the drivers of satisfaction and retention of an advanced practice workforce.

Journal of the American Association of Nurse Practitioners·2026

Search research articles

Related Experiment Video

Updated: Jan 20, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Genomics and breast cancer screening.

April L Tyler¹

¹Maryville University, St. Louis, Missouri.

Journal of the American Association of Nurse Practitioners

|September 7, 2019

Summary

Genetic testing helps identify women at high risk for breast cancer, enabling preventative actions like medication and surgery. Early detection through genetic screening is crucial for effective patient care and cancer prevention.

Area of Science:

Oncology
Medical Genetics

Background:

Family history significantly increases breast cancer risk for some women.
Advances in genetics offer tools to identify at-risk individuals.
Understanding cancer genetics is key to risk assessment.

Purpose of the Study:

To outline genetic testing protocols for women at risk of hereditary breast cancer.
To emphasize the importance of screening and preventative measures for at-risk populations.
To inform healthcare providers about essential components of genetic breast cancer care.

Main Methods:

Risk assessment tests
Genetic counseling
Genetic testing

Main Results:

More Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Related Experiment Videos

Last Updated: Jan 20, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Genetic testing protocols enable identification of women with increased hereditary breast cancer risk.
Preventative actions include medication, surgery, and intensive screenings.
These protocols facilitate both cancer prevention and early detection.

Conclusions:

Appropriate screening, including risk assessment, genetic counseling, and testing, is essential for managing genetic breast cancer risk.
Healthcare providers need a foundational understanding of cancer genetics and available preventative measures.
Proactive management through genetic insights improves patient care and outcomes for hereditary breast cancer.